tirzepatide double dose (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus Tirzepatide (Zepbound) for weight loss

SiPhox Health At-Home Blood Test Monitoring made simple

In the SURPASS clinical program (phase III development programs for T2D), doses of 5, 10, and 15 mg, which are attained following a stepwise dose escalation, are being studied

One such option is Mounjaro (tirzepatide), a once-weekly injectable medication that was originally approved for type 2 diabetes and is now FDA-approved for weight management in adults with obesity or overweight and at least one weight-related health condition

[DOI] [PubMed] [Google Scholar] 6.Davies MJ, Aroda VR, Collins BS, et al

And both have become the most-searched weight loss medications in the world